SCHEMBL30848232

SCHEMBL30848232

N#Cc1cc(C(N)=O)cc(Br)c1CO

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.37
TSHR P16473 1/20 0.37
APOBEC3A P31941 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
NCOA1 Q15788 1/20 0.36
NCOA3 Q9Y6Q9 1/20 0.36
ALDH1A1 P00352 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP11B2 P19099 1/20 0.33
CYP3A4 P08684 1/20 0.33
PARP1 P09874 1/20 0.33
PARP15 Q460N3 1/20 0.32
PARP10 Q53GL7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29172047 1.00 HTT (0.37) HTTTSHRAPOBEC3AAPOBEC3GNCOA1
SCHEMBL30848231 0.85 TTR (0.44) ALDH1A1
SCHEMBL29171894 0.85 TTR (0.44) ALDH1A1
SCHEMBL29171956 0.80 KDM4E (0.39) ALDH1A1SMN1; SMN2KDM4ELMNAPOLB
SCHEMBL30848324 0.80 AR (0.34) ALDH1A1SMN1; SMN2MAPTAR
SCHEMBL29171893 0.78 TTR (0.42) HTTTSHRAPOBEC3AAPOBEC3GNCOA1
SCHEMBL30848158 0.75 HTT (0.40) HTTTSHRAPOBEC3AAPOBEC3GNCOA1
SCHEMBL29171993 0.75 HTT (0.40) HTTTSHRAPOBEC3AAPOBEC3GNCOA1
SCHEMBL3277968 0.73 PARP1 (0.44) TSHRSMN1; SMN2CYP11B2PARP1PARP15
SCHEMBL29172061 0.73 CYP11B1 (0.35) MEN1KMT2ACYP11B2ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117720472-A Benzimidazole compound, and preparation method and application thereof 苏州沪云新药研发股份有限公司 2024-03-19 CN disclosed